Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Agata Xella"'
Autor:
Michelle M. Kameda-Smith, Helen Zhu, En-Ching Luo, Yujin Suk, Agata Xella, Brian Yee, Chirayu Chokshi, Sansi Xing, Frederick Tan, Raymond G. Fox, Ashley A. Adile, David Bakhshinyan, Kevin Brown, William D. Gwynne, Minomi Subapanditha, Petar Miletic, Daniel Picard, Ian Burns, Jason Moffat, Kamil Paruch, Adam Fleming, Kristin Hope, John P. Provias, Marc Remke, Yu Lu, Tannishtha Reya, Chitra Venugopal, Jüri Reimand, Robert J. Wechsler-Reya, Gene W. Yeo, Sheila K. Singh
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-19 (2022)
MYC amplification is an independent prognostic factor for the most aggressive subgroup (Group 3) of pediatric medulloblastoma (G3 MB). Here, the authors highlight the role of the RNA-binding protein, Musashi-1 (MSI1) in G3 MB and identify MSI1-bound
Externí odkaz:
https://doaj.org/article/3eace71e4f774decb598d79c690ed3aa
Autor:
Alexander B. Brummer, Agata Xella, Ryan Woodall, Vikram Adhikarla, Heyrim Cho, Margarita Gutova, Christine E. Brown, Russell C. Rockne
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
In the development of cell-based cancer therapies, quantitative mathematical models of cellular interactions are instrumental in understanding treatment efficacy. Efforts to validate and interpret mathematical models of cancer cell growth and death h
Externí odkaz:
https://doaj.org/article/3ed9f3f43ccd4e5b86bbe4ee26323978
Autor:
Michelle M. Kameda-Smith, Helen Zhu, En-Ching Luo, Yujin Suk, Agata Xella, Brian Yee, Chirayu Chokshi, Sansi Xing, Frederick Tan, Raymond G. Fox, Ashley A. Adile, David Bakhshinyan, Kevin Brown, William D. Gwynne, Minomi Subapanditha, Petar Miletic, Daniel Picard, Ian Burns, Jason Moffat, Kamil Paruch, Adam Fleming, Kristin Hope, John P. Provias, Marc Remke, Yu Lu, Tannishtha Reya, Chitra Venugopal, Jüri Reimand, Robert J. Wechsler-Reya, Gene W. Yeo, Sheila K. Singh
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-1 (2023)
Externí odkaz:
https://doaj.org/article/a3f8e3d5b4894e4aa4350454d71f0f4e
Autor:
John Williams, Christine Brown, Brenda Aguilar, Stephen Forman, Miso Park, Cheng-Fu Kuo, Yi-Chiu Kuo, Zhen Tong, Agata Xella, Vanessa Salvary
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/6e71636acca7478398f6ce3e0e39ecd5
Publikováno v:
Methods in Cell Biology ISBN: 9780323901543
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d175e641b17a6e1956b2d4df13ac7fd
https://doi.org/10.1016/bs.mcb.2022.07.010
https://doi.org/10.1016/bs.mcb.2022.07.010
Autor:
Michelle Kameda-Smith, Helen Zhu, EnChing Luo, Chitra Venugopal, Agata Xella, Brian Yee, Sansi Xing, Frederick Tan, Raymond Fox, Kevin Brown, Ashley Adile, David Bakhshinyan, Chirayu Chokshi, William Gwynne, Minomi Subapanditha, Daniel Picard, Ian Burns, Jason Moffat, Adam Fleming, Kristin Hope, John Provias, Marc Remke, Yu Lu, Tannishtha Reya, Jüri Reimand, Robert Wechsler-Reya, Gene Yeo, Sheila Singh
Pediatric medulloblastoma (MB) is the most common solid malignant brain neoplasm, with Group 3 (G3) MB representing the most aggressive subgroup. MYC amplification is an independent poor prognostic factor in G3 MB, however, therapeutic targeting of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17e27de6d31d7ca511e8830c52500833
https://doi.org/10.21203/rs.3.rs-549885/v1
https://doi.org/10.21203/rs.3.rs-549885/v1
Autor:
Christine E. Brown, Agata Xella, Jonathan C. Hibbard, Vanessa Salvary, Brenda Aguilar, Jamie Wagner, Bruce Dezube, Knut Niss, Lynn Bayless, James Edinger, Jianmei Leavenworth, Stephen J. Forman, Behnam Badie, James M. Markert, Kevin A. Cassady
Publikováno v:
Cancer Research. 82:CT541A-CT541A
The combination of chimeric antigen receptor (CAR) T cell therapy, which delivers large numbers of tumor reactive T cells, and oncolytic viral therapy, causing activation of host immune responses, is an attractive approach for improving outcomes for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5634b0b04c9e714bf0919ce4bc70f85d
https://doi.org/10.1158/1538-7445.am2022-ct541a
https://doi.org/10.1158/1538-7445.am2022-ct541a
Autor:
Agata Xella, Christine E. Brown, Miso Park, Cheng-Fu Kuo, Zhen Tong, Vanessa Salvary, Yi-Chiu Kuo, John C. Williams, Brenda Aguilar, Stephen J. Forman
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundMeditope is a small cyclic peptide that was identified to bind to cetuximab within the Fab region. The meditope binding site can be grafted onto any Fab framework, creating a platform to uniquely and specifically target monoclonal antibodie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2db231bf0aa378511b2c99b1b0f11bb
https://doi.org/10.1136/jitc-2021-sitc2021.124
https://doi.org/10.1136/jitc-2021-sitc2021.124
Autor:
David Bakhshinyan, Marc Remke, En-Ching Luo, Kristin Hope, Provias John, Sansi Xing, Raymond G. Fox, Jason Moffat, Gene W. Yeo, Yu Lu, Frederick E. Tan, Ashley Adile, Chitra Venugopal, Helen He Zhu, Kevin R. Brown, Brian A. Yee, Minomi Subapanditha, Jüri Reimand, Agata Xella, Tannishitha Reya, Adam Fleming, Michelle Kameda-Smith, Robert J. Wechsler-Reya, Daniel Picard, Sheila K. Singh
Publikováno v:
Neuro-Oncology
Medulloblastoma (MB) is the most common solid malignant pediatric brain neoplasm, with Group 3 (G3) MB representing the most aggressive subgroup. MYC amplification is an independent poor prognostic factor in G3 MB, however, therapeutic targeting of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7d62f398119b5f1086b87754a1af009
http://europepmc.org/articles/PMC7715904
http://europepmc.org/articles/PMC7715904